Distinct profiles and kinetics of soluble inflammatory markers in patients with acute and chronic HCV-infections and SARS-CoV-2-infections: Implications for the long-term consequences of viral infections?

Abstract

Background and Aims Viral infections occur acutely but can also progress chronically, with the immune system having a central role in immunopathogenesis. The question arises whether all alterations in immune responses are reversible after viral elimination (spontaneously or by therapy). Therefore, the aim of this study is to compare soluble inflammatory markers (SIM) during and after infection with SARS-CoV-2 and acute and chronic HCV-infections.

Patients and Method Patients with acute HCV (n=29), chronic HCV (n=54), SARS-CoV-2 (n=39) and 31 healthy-controls were included. Blood samples were tested at baseline, end of treatment/infection, and follow-up (≥9 months after baseline). IL-12p70, IL-1b, IL-4, IL-5, IL-6, IL-8, TNF, IFN-g, IL-10, IL-22, CXCL-10, MCP-1, MIP-1b, ITAC were quantified using the HD-SP-X Imaging and Analysis SystemTM.

Results SIM profiles in patients with acute HCV were substantially elevated at baseline and the decrease during follow-up was considerably less compared to the SARS-CoV-2 cohort. In chronic HCV-patients, viral elimination by therapy resulted in a decrease in SIM, although not always to those of controls. Cirrhotic HCV patients had higher SIM levels after HCV elimination than non-cirrhotic chronic HCV-patients. In the SARS-CoV-2 cohort, most SIM returned to levels of controls 3 months after baseline.

Conclusions SIM profiles and kinetics after viral elimination differ between blood-borne acute and chronic HCV- and respiratory SARS-CoV-2-infections. The immunologic imprint 9 months after cured HCV-infection (both acute and chronic) appears to be more pronounced than after SARS-CoV-2-infection. Further analysis is needed to correlate the SIM profile with the clinical phenotype (long-HepC vs. long-COVID-19).

Publikationsverlauf

Artikel online veröffentlicht:
18. Januar 2023